FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds with structural formulas , as follows and their stereoisomers, wherein Y represents or and using them for an agent for treating and/or preventing glaucoma and/or ocular hypertension.
EFFECT: treating and/or preventing glaucoma and/or ocular hypertension.
7 cl, 32 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED GAMMA-LACTAMS AS THERAPEUTIC AGENTS | 2006 |
|
RU2412933C2 |
THERAPEUTIC SUBSTITUTED LACTAMS | 2008 |
|
RU2481342C9 |
SUBSTITUTED CYCLOPENTANS POSSESSING PROSTAGLANDIN ACTIVITY | 2008 |
|
RU2481339C2 |
COMPOUNDS AND METHODS OF INHIBITING INTERACTION OF BCL PROTEINS WITH BINDING COMPONENTS | 2005 |
|
RU2416606C2 |
P38 INHIBITORS AND APPLICATION METHODS | 2004 |
|
RU2357957C2 |
SUBSTITUTED CYCLOPENTANES, POSSESSING PROSTAGLANDIN ACTIVITY | 2009 |
|
RU2505530C2 |
MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
THERAPEUTIC SUBSTITUTED CYCLOPENTANES | 2009 |
|
RU2501789C2 |
NON-ANNELATED TYOPHENYLAMIDS AS INHIBITORS OF FATTY ACIDS FABP 4 AND / OR 5 BINDING PROTEINS | 2013 |
|
RU2647587C2 |
MACROCYCLIC ANALOGUES AND METHODS OF THEIR APPLICATION AND PREPARATION | 1999 |
|
RU2822750C2 |
Authors
Dates
2015-02-27—Published
2009-04-22—Filed